conjugated estrogen
1.Dixon GW，Schelsselman JJ，Ory HW，et al.Ethinyl estradiol and conjugated estrogen as post-coital contraceptives［J］.JA-MA，1980，244:1336.
2.To study the effects of medroxyprogesterone acetate (MPA) and conjugated estrogen (CE) plus MPA replacement on menopausal symptoms, serum lipid profile, bone mineral surface density (BMSD) and biochemical bone markers in postmenopausal women.
3.Objective:To study the effect and compliance of onjugated estrogen in the treatment of climacteric syndrome Methods:114 patients with climacteric syndrome were randomly divided into two groups,the study group with 69 patients and the controlled group with 45 patients Patients of the study group intake conjugated estrogen orally 0 625 mg per day,28 days for a period,added with MPA(Medroxyprogesteme acetate)4 mg per day during the 15th to 28th days of every period.
